prof. MUDr. Mgr. Marek Mráz, Ph.D.
Research Group Leader Senior, Marek Mráz Research Group
Office: bldg. E35/216
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 8143 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 267
2023
-
Způsob stanovení prognózy u pacientů s folikulárním lymfomem
Publisher: Úřad průmyslového vlastnictví, state: Czech Republic, patent's number: 309489, year: 2023
2022
-
Adaptace buněk chronické lymfocytární leukémie na cílenou léčbu BCR inhibitory.
Year: 2022, type: Conference abstract
-
Diagnostická sada pro stanoveni prognózy folikulárního lymfomu s pomocí kvantifikace miRNA
Year: 2022
-
GAB1 as novel therapeutic target in B lymphoid and myeloid malignancies
Year: 2022, type: Conference abstract
-
Genetic mechanism for the loss of PRAME in B cell lymphomas
Journal of Clinical Investigation, year: 2022, volume: 132, edition: 14, DOI
-
High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL
BLOOD ADVANCES, year: 2022, volume: 6, edition: 18, DOI
-
In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug Testing
CANCERS, year: 2022, volume: 14, edition: 13, DOI
-
Modelling chronic lymphocytic leukaemia microenvironment.
Year: 2022, type: Conference abstract
-
Synthesis and Profiling of Highly Selective Inhibitors of Methyltransferase DOT1L Based on Carbocyclic C-Nucleosides
Journal of Medicinal Chemistry, year: 2022, volume: 65, edition: 7, DOI
-
The role of long non-coding RNAs in BCR-mediated CLL activation.
Year: 2022, type: Conference abstract